m-RESIST Newsletter Issue 2 | July 2017
Email not dislpaying correctly? View it in your browser.


Dear readers,

We are very glad to introduce you the second newsletter of the m-RESIST project.

m-RESIST is running the last six-month period of its three-year course.  Issue 2 focuses on presenting the latest achievements and results of the project. In this newsletter, you will have the opportunity to read our project news, past events and publications as well as upcoming events.

Thank you for your interest in our work! Enjoy the reading!
The m-RESIST consortium

What is m-RESIST? A quick overview

m-RESIST is a 36-months EU co-funded project under the Horizon 2020 research and innovation framework program. The Project aims to develop a therapeutic program that provides clinical and psychological tools that draw on the support of mobile devices. We consider this m-Health approach will help to actively involve patients with treatment-resistant schizophrenia and their caregivers, as well as to make them more capable of self-managing their own illness.

Launched in January 2015, m-RESIST is expected to implement a model of analysis, in order to move forward in understanding treatment-resistant schizophrenia. Project activities will help to predict patient’s behaviour and will allow the establishment of a reaction alert system, as well as to draw up protocols and recommendations to give clinicians support in their medical decisions. By linking data mining tools with a high-level predictive model, m-RESIST will bring forth a new technical focus for health treatments. This will allow the behaviour patterns found in many patients’ data to be analysed in order to identify the risks and shortcomings of the treatments.

Project News

First release of the m-RESIST Solution

During the second year, all the efforts have been put in the actual development and testing of the m-RESIST Tools. Activities range from working together with the clinical partners to specify user requirements, agile implementation and applied testing and evaluation. The envisioned solution is now available for piloting. 


Pre-pilot study of the m-RESIST system

From March 2017 to May 2017, the m-RESIST pre-pilot study was conducted at Semmelweis University in Budapest (Hungary). Twenty clinicians from the University hospital participated and shared their opinions about the two m-RESIST tools namely, the mobile application and the Patient Data Dashboard, a website used only by clinicians.

The aim of the study was threefold: 1) to get an understanding of the user experience, 2) to test whether all the features of the app and the website work properly and 3) to collect recommendations to guide the future development of the platform. The overall findings from this study have been positive and the results show that the m-RESIST platform was welcomed by the participants and that they found the two tools understandable, easy to use and clear. Additionally, the layout of both the m-RESIST app and website were characterized as nice. With regard to whether or not the m-RESIST system would ease the work of the clinicians and support patients manage their illness, participants stated that if all the users (patients, caregivers and clinicians) managed to use the m-RESIST platform effortlessly then everyone would benefit from it. These findings have made it possible to further improve the platform and they have given us the confidence that we are on the right track prior to the pilots. 


m-RESIST video about mHealth

In December 2016 m-RESIST Consortium created a video, “The Last Guitarist”, which is about a patient with treatment-resistant schizophrenia followed by Parc Sanitari Sant Joan de Déu’s clinical team, who is talking about the disease and mHealth. The video is available below!
The Last Guitarist

Did you know that?

m-RESIST Consortium has already published several articles in scientific journals and conferences and has been presented in several events, succeeding in raising the awareness of the project to its relevant stakeholders. Some indicative publications and events can be found below.

Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study has been published in JMIR mHealth and uHealth Journal, 2016.

Free context smartphone based application for motor activity levels recognition” has been released in 2016 IEEE 2nd International Forum on Research and Technologies for Society and Industry Leveraging a better tomorrow (RTSI).

“Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis” has been published in Early Intervention in Psychiatry, 2017.


m-RESIST was presented at the workshop "At the borders of science and art" during the European Researchers’ Night in Linnanmaa campus of the University of Oulu in Finland, on 30 September 2016. Annika Seppälä (OULU) gave a Pecha Kucha presentation about m-RESIST and more specifically on "Mobile technology in the treatment of mental illness"

In September 2016 m-RESIST was presented during the 6th Jornades TIC Salut i Social 2016, that was held in Vic (Spain). During the symposium, a poster and an oral communication about “Measuring users' receptivity towards an integral intervention model based on m-health solutions for patients with treatment-resistant schizophrenia (m-RESIST): a qualitative study” were presented by researchers members of Parc Sanitari Sant Joan de Déu (PSSJD) and Hospital de Sant Pau (HSP).

In addition, m-RESIST Poster “Measuring users' receptivity towards an integral intervention model based on m-health solutions for patients with treatment-resistant schizophrenia (m-RESIST): a qualitative study” was presented by PSSJD at the 12th Jornades de Recerca, on November 2016 and has won an award for the best poster presentation.

In January and February, 2017 Erika Jääskeläinen (OULU) talked about mHealth in psychoses and m-RESIST in Oulu Psychiatric Epidemiology Society meeting and gave a poster presentation “Mobile therapeutic attention for patients with treatment-resistant schizophrenia – mRESIST” at the Science Day of the University of Oulu.

In April 2017 Matti Isohanni (OULU) and Judith Usall (PSSJD), chaired the Workshop “Treatment-Resistant Schizophrenia: Epidemiology, Clinical Course and Innovative Treatments, with Special Reference to m-RESIST Project”, during the 25th European Congress of Psychiatry (EPA 2017), held in Florence, Italy. During the workshop the following presentations took place:
  • "Definition, Epidemiology, Clinical Course, and Outcomes in Treatment-resistant Schizophrenia", Jussi Seppala (OULU)
  • "Emerging Sensor-based M-health Interventions in the Assessment of Psychotic Symptoms", Maria Bulgheroni (ABACUS)
  • "Identifying Service and Care Needs from the Users' Perspective in Treatment-Resistant Schizophrenia", Katya Rubinstein (GERTNER)
  • " m-RESIST project as an example of m-health approach in schizophrenia: Content, aims and realization”, Illuminada Corripio (HSP)
On 18 April 2017, Jouko Miettunen and Teija Juola (OULU) participated at University of Oulu eHealth Seminar and Demo day arranged for the medical students and companies or scientific projects. m-RESIST was presented via poster and discussion as a new way of treating schizophrenia patients.

Furthermore, on May 2017, Iluminada Corripio and Eva Grasa (HSP) presented the poster “m-RESIST, a modular intervention programme addressed to patients with treatment-resistant schizophrenia” during the 17th International Conference on Integrated Care that was held in Dublin.

Where to look next!

  1. A new article entitled “m-RESIST, a complete m-Health solution for patients with treatment-resistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area”, has been submitted by PSSJD in Actas Españolas de Psiquiatría, the most important psychiatry journals in Spain. The article has been accepted and pending for publication.
  2. m-RESIST will be presented at the 6th European Conference on Schizophrenia Research (ECSR) to be held in Berlin, Germany from 14 - 16 September 2017. Oulu team will organise there a symposium “Optimizing the path to recovery in treatment-resistant and difficult-to treat schizophrenia: Challenges and alternatives” that will be chaired by Matti Isohanni and Eva Grasa and will include four presentations by m-RESIST members.
  3. A poster communication about “Gender Differences in Carers of Patients with Schizophrenia: a qualitative study”, based on the previous research work of focus groups with users, will be presented by PSSJD at the European Meeting on Women's Mental Health to be held in Barcelona on 26 and 27 October 2017. 

Who are we?

Contact information
Project coordinator
Margarita Hospedales Salomo, FUNDACIO TICSALUT (Spain)


Do you want to be part of it or know about it?

Copyright © 2017 m-RESIST - All rights reserved.

This project is co-funded by the Horizon 2020 Framework Programme of the European Union under grant agreement no [643552].

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
m-RESIST Project · An EU-Funded project by H2020 programme · Mobile Therapeutic Attention for patients with Treatment Resistant Schizophrenia 643552 · Belgium

Email Marketing Powered by Mailchimp